Skip to main content
OpenTrials

Clinical trial condition

Cancer

Explore clinical trials studying Cancer. Study availability and eligibility vary by location and protocol.

3,029 public trials 600 recruiting studies
Refine in advanced search Browse all conditions

Cancer trial results

Completed

PTC596 in Patients With Advanced Solid Tumors

NCT02404480

Conditions
Cancer, Neoplasms
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Durham, North Carolina, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor

NCT01231568

Conditions
Cancer, Neoplasms
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
View Trial Details
Completed

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

NCT01954043

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Dallas, Texas, United States
  • GSK Investigational Site Tacoma, Washington, United States
  • GSK Investigational Site Heidelberg, Victoria, Australia
View Trial Details
Completed

A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors

NCT00880321

Conditions
Cancer, Neoplasms
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Houston, Texas, United States
View Trial Details
Completed

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

NCT01340846

Conditions
Cancer, Neoplasms
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Sarasota, Florida, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Columbus, Ohio, United States
View Trial Details

Related conditions